✦ LIBER ✦

Combination chemotherapy of small-cell bronchogenic carcinoma with etoposide (VP-r6), ifosfamide and vindesine (VPIV), and with adriamycin, cis-platinum and vincristine (APO)

✍ Scribed by Havemann, K.

Book ID: 123558592
Publisher: Elsevier Science
Year: 1982
Tongue: English
Weight: 400 KB
Volume: 9
Category: Article
ISSN: 0305-7372
DOI: 10.1016/S0305-7372(82)80086-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemoimmunotherapy of small cell broncho

Chemoimmunotherapy of small cell bronchogenic carcinoma with VP-16-213, ifosfamide, vincristine, adriamycin, and Corynebacterium Parvum

✍ Dr. Manuel Valdivieso; Theodore F. Tenczynski; Victorio Rodriguez; Michael A. Bu 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 595 KB

Combination chemotherapy with adriamycin

Combination chemotherapy with adriamycin, ifosfamide and mesna in extensive-stage non-small cell bronchogenic carcinoma

✍ Matthiessen, W.; Stempinski, Erna; Göbel, D.; Thalmann, U. 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Combined chemotherapy with ifosfamide an

Combined chemotherapy with ifosfamide and cisplatin and with ifosfamide and etoposide (VP-16) in non-small cell carcinoma of the bronchus

✍ Manke, H.G.; Drings, P.; Stiefel, P.; Schmitteckert, H.; Grimm, V.; Kleckow, M. 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 372 KB

Treatment of inoperable non-small-cell b

Treatment of inoperable non-small-cell bronchogenic carcinoma with etoposide and cis-platinum

✍ Mitrou, P.S.; Fischer, M.; Weissenfels, I.; Diehl, V.; Gropp, C.; Liesenfeld, A. 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 258 KB

Chemotherapy combination with cyclophosp

Chemotherapy combination with cyclophosphamide (CTX) adriamycin (ADM), vincristine (VCR), and VP16-213 in small cell carcinoma of the lung (SCCL)

✍ J. M. Gracia; A. Jimenez 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 178 KB

Twenty-four evaluable patients with small cell carcinoma of the lung were treated with an escalating chemotherapy regimen including Cyclophosphamide, Adriamycin, Vincristine and VP16-213. The initial doses were CTX 800 mg/m2 i.v. day 1; ADR 50 mg/m2 i.v. day 1; VCR 1.4 mg/m2 day 1 weekly; and VP16-2

Combination chemotherapy with cisplatin,

Combination chemotherapy with cisplatin, adriamycin, etoposide and cyclophosphamide for small cell carcinoma of the lung (SCLC)

📂 Article 📅 1985 🏛 Elsevier Science ⚖ 155 KB